Brind.

Partnership between Cardinal Health and bioAffinity Technologies improves sample tracking and delivery reliability.

1 report, 1 independent Updated Aug 14

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Cardinal Health

Keep exploring

The entities involved

Cardinal Health
Healthcare company
- Morgan Stanley raised its price target for Cardinal Health on August 8, 2025.Sun 07:34
- Trump's pledge to unleash oil and gas benefits certain stocks.Sun 02:30

Coverage

Newest first; wire copies grouped

Aug 14Business WirebioAffinity Technologies Reports Second Quarter 2025 Results CyPath® Lung revenues up 62% year-over-year in first six months of 2025 SAN ANTONIO, August 14, 2025--(BUSINESS WIRE)--bioAffinity Technol